PSA/fPSA immunoassay analysis

Monday, 01 December, 2008 | Supplied by: Olympus Australia Pty Ltd


Olympus has released PSA and fPSA assays for the Olympus AU3000i immunoassay analyser. The assays feature assay sensitivity of 0.015 µg/L. In the monitoring of patients after prostate cancer treatment, the sensitive PSA assay is suitable for the detection of recurrence of the disease.

The assays use a two-step immunometric design, minimising the risk of high-dose-hook and ensuring that the measurement of samples with elevated PSA levels will generate appropriate results. No high-dose-hook has been observed at PSA concentrations up to 160,000 µg/L, according to Olympus.

Other available test panels for the AU30001 include the primary tumour marker panel (AFP, CEA, PSA and fPSA) and the specialist tumour markers GI TN-TC and BR-TC.

 

Online: www.olympusaustralia.com.au
Phone: 03 9265 5400
Related Products

Meridian Bioscience Specimen-specific, inhibitor-tolerant master mixes

Scientists can skip DNA/RNA extraction with Meridian's inhibitor-tolerant, specimen-specific...

Molecular Devices microplate readers

A microplate reader is an essential instrument for a vast range of applications, from basic...

Dojindo Cytotoxicity LDH Assay Kit-WST

Dojindo's Cytotoxicity LDH Assay Kit-WST can be applied with or without supernatant transfer...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd